The epidemiology of cardiovascular disease in the UK 2014

Cardiovascular disease (CVD) presents a significant burden to the UK. This review presents data from nationally representative datasets to provide up-to-date statistics on mortality, prevalence, treatment and costs. Data focus on CVD as a whole, coronary heart disease (International Classification of Diseases (ICD):I20–25) and cerebrovascular disease (ICD:I60–69); however, where available, other cardiovascular conditions are also presented. In 2012, CVD was the most common cause of death in the UK for women (28% of all female deaths), but not for men, where cancer is now the most common cause of death (32% of all male deaths). Mortality from CVD varies widely throughout the UK, with the highest age-standardised CVD death rates in Scotland (347/100 000) and the North of England (320/100 000 in the North West). Prevalence of coronary heart disease is also highest in the North of England (4.5% in the North East) and Scotland (4.3%). Overall, around three times as many men have had a myocardial infarction compared with women. Treatment for CVD is increasing over time, with prescriptions and operations for CVD having substantially increased over the last two decades. The National Health Service in England spent around £6.8 billion on CVD in 2012/2013, the majority of which came from spending on secondary care. Despite significant declines in mortality in the UK, CVD remains a considerable burden, both in terms of health and costs. Both primary and secondary prevention measures are necessary to reduce both the burden of CVD and inequalities in CVD mortality and prevalence.

[1]  Spiros C. Denaxas,et al.  Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study , 2013, BMJ.

[2]  R. Magno,et al.  Coronary heart disease , 1957 .

[3]  M. Goldacre,et al.  Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study , 2012, BMJ : British Medical Journal.

[4]  Peter Scarborough,et al.  Cardiovascular disease in Europe 2014: epidemiological update. , 2013, European heart journal.

[5]  Antonio Colombo,et al.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial , 2013, The Lancet.

[6]  Mike Rayner,et al.  Cardiovascular disease statistics 2014 , 2014 .

[7]  Peter Scarborough,et al.  Coronary heart disease statistics 2010 , 2010 .

[8]  M. Murphy,et al.  The health of adult Britain 1841-1994. , 1997 .

[9]  John G. Williams.  Monitoring clinical activity and performance: how can hospital episode statistics be made fit for purpose? , 2011, Frontline Gastroenterology.

[10]  M. Cowie,et al.  UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database , 2011, BMJ Open.

[11]  T. V. van Staa,et al.  Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource , 2012, Therapeutic advances in drug safety.

[12]  S. Allender,et al.  European cardiovascular disease statistics , 2008 .

[13]  K. Bennett,et al.  Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008 , 2013, BMC Public Health.

[14]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[15]  Simon Capewell,et al.  Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.